Stay updated on JCARH125 in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the JCARH125 in Multiple Myeloma Clinical Trial page.

Latest updates to the JCARH125 in Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedAn NIH site-wide notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content.SummaryDifference1%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision advanced from v3.7.1 to v3.7.2 while the study page continued to show a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check37 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, with a minimal header/footer and a Home button. The page also notes a site revision (Revision: v3.7.0).SummaryDifference21%

- Check58 days agoChange DetectedRevision tag on the page was updated from v3.6.5 to v3.6.6.SummaryDifference0.0%

- Check65 days agoChange DetectedThe related topics and guidance items for the study page are shortened by removing the disease keyword and a genetics-related link, affecting contextual labels rather than substantive study information.SummaryDifference0.1%

Stay in the know with updates to JCARH125 in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCARH125 in Multiple Myeloma Clinical Trial page.